Gintsburg Reports Russian Cancer Vaccine Eliminated Metastases in First Patient
Scientific Director of the Gamaleya Center, Academician of the Russian Academy of Sciences Alexander Gintsburg reported that the first patient had metastases disappear after receiving the Russian cancer vaccine. The patient will be monitored for three years.

Gintsburg shared this information in an interview with *Gazeta.Ru*. According to him, the patient is examined every month, and Andrei Kaprin, the head of the National Medical Research Center of Radiology of the Russian Ministry of Health, performs high-resolution computed tomography scans on him.
Specialists check the lymph nodes and conduct a full-body examination of the patient—from head to toe. At the time of the interview, four months had passed since the disappearance of the metastases, and the patient's condition remained stable. Monitoring will continue for three years.
Gintsburg explained that the cancer vaccine is designed to reprogram the immune system so that it independently destroys malignant tumors and metastases. The drug is created individually for each patient based on their genetic data; the academician noted that no two tumors are identical.
On October 1, Russian Minister of Health Mikhail Murashko reported that the first Russian patients with oncological diseases are already receiving vaccines and treatment using the CAE-T-cell therapy method free of charge under the compulsory medical insurance system. On September 15, Murashko stated that the risk of developing oncological diseases will increase over the next 25 years due to rising life expectancy.





